Today: 4 June 2026

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Hong Kong Stock Market Today: Hang Seng Set for Thin Christmas Eve Half-Day as Wall Street Hits Record, China AI Theme in Focus (Dec. 24, 2025)

Hong Kong Stock Market Today: Hang Seng Set for Thin Christmas Eve Half-Day as Wall Street Hits Record, China AI Theme in Focus (Dec. 24, 2025)

Hong Kong’s stock market opened Wednesday for a half-day session, with trading set to end around noon ahead of the Christmas holiday. Hang Seng Index futures pointed slightly lower before the bell, after the index slipped 0.11% to 25,774.14 on Tuesday. Liquidity is expected to be thin, with no trading on Dec. 25 and 26. U.S. markets closed at record highs overnight.
24 December 2025
India Stock Market Today (Dec 24, 2025): GIFT Nifty Signals Mildly Positive Open; RBI Liquidity Boost, Rupee Watch, Key Levels and Stocks in Focus

India Stock Market Today (Dec 24, 2025): GIFT Nifty Signals Mildly Positive Open; RBI Liquidity Boost, Rupee Watch, Key Levels and Stocks in Focus

GIFT Nifty futures rose 52 points before the open Wednesday, signaling a mildly positive start as Nifty and Sensex hover near record highs. Sensex closed at 85,524.84 on Tuesday, down 42.64 points; Nifty 50 edged up 4.75 points to 26,177.15. Foreign investors sold ₹1,795 crore while domestic funds bought ₹3,812 crore. RBI’s planned ₹2 trillion bond purchase and $10 billion swap are in focus.
24 December 2025
Singapore Stock Market Today: SGX Eyes a Quiet Christmas Eve Open After STI’s Record Close (24 Dec 2025)

Singapore Stock Market Today: SGX Eyes a Quiet Christmas Eve Open After STI’s Record Close (24 Dec 2025)

Singapore’s Straits Times Index closed at a record 4,638.97 on Dec 23, up 0.6%, led by gains in DBS, OCBC, and UOB. Core inflation held steady at 1.2% in November, slightly below forecasts. Trading volume is expected to be thin ahead of Christmas, with the SGX running a half-day session. The STI is up about 22% for the year.
24 December 2025
····
Tokyo Stock Market Today: Nikkei 225 Set for a Cautious Christmas Eve Open as Wall Street Records Clash With Yen Volatility (Dec. 24, 2025)

Tokyo Stock Market Today: Nikkei 225 Set for a Cautious Christmas Eve Open as Wall Street Records Clash With Yen Volatility (Dec. 24, 2025)

OSE Nikkei 225 futures for March 2026 opened at 50,560, up 70 yen from the prior settlement, signaling a modestly positive tone ahead of Tokyo’s Dec. 24 session. TOPIX futures dipped 5 points to 3,426.5. U.S. stocks hit new records overnight, but thin holiday liquidity and yen volatility may limit gains for Japanese exporters. Japan’s finance minister issued a strong warning on potential currency intervention.
24 December 2025
··
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 23.12.2025

Rocket Lab shares fell after director Merline Saintil sold 5,000 shares, cutting her stake by 1.27%. The stock opened at $73.81, down from $77.55, despite a new $805–816 million defense contract and a successful Electron launch. In India, the Sensex slipped 43 points to 85,524.84 while the Nifty 50 closed at 26,177.15 in a quiet session. MarketSmith India issued buy calls on Bajaj Auto and SJS Enterprises.
23 December 2025
··
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 22.12.2025

Anfield Energy Inc. (0ADN.F) traded flat at €0.065 on XETRA, with Meyka AI projecting a 12-month target of €0.285, citing uranium and vanadium sector momentum. Nvidia’s AI-driven data center business is drawing investor attention for 2026, as Tesla’s Q3 2025 margins slipped to 5.8% and growth slowed.
22 December 2025
·
Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

BioMarin agreed to acquire Amicus Therapeutics for $4.8 billion on Dec. 19, paying a 33% premium and adding two rare-disease drugs with $599 million in combined annual sales. The deal, plus an FDA approval for Cytokinetics and new IPO filings, drove biotech stocks higher ahead of the Christmas-shortened trading week. U.S. markets will close early Dec. 24 and remain shut Dec. 25.
21 December 2025
·····
Pharma Stocks Week Ahead (Dec. 22–26, 2025): Drug-Pricing Deals, FDA Catalysts, and M&A to Watch

Pharma Stocks Week Ahead (Dec. 22–26, 2025): Drug-Pricing Deals, FDA Catalysts, and M&A to Watch

President Trump and nine major drugmakers announced deals on Dec. 19 to cut Medicaid and cash-pay drug prices, shifting U.S. pharma policy focus. Shares of most participating firms rose 1%–3%. Trading in the week of Dec. 22–26 is expected to be volatile due to thin holiday liquidity and headline sensitivity. U.S. markets will close early Dec. 24 and remain shut Dec. 25.
21 December 2025
·········
Nuclear Stocks Week Ahead (Dec 22–26, 2025): Uranium Near $80, Centrus Fuel-Chain Catalyst, and SMR Volatility in Focus

Nuclear Stocks Week Ahead (Dec 22–26, 2025): Uranium Near $80, Centrus Fuel-Chain Catalyst, and SMR Volatility in Focus

Uranium prices held near $80.25/lb on Dec. 19, 2025, up 1.58% from the prior day, as nuclear stocks saw volatile moves in thin holiday trading. Centrus Energy issued a major enrichment supply-chain update, while renewed debate focused on small modular reactor firms Oklo and NuScale. U.S. markets will close early Dec. 24 and remain shut Dec. 25, amplifying swings in nuclear and uranium equities.
21 December 2025
··
Space & Satellite Tech Stocks Week Ahead: Rocket Lab’s $816M Space Force Win, AST SpaceMobile’s BlueBird 6 Launch, and EchoStar’s Spectrum Spotlight

Space & Satellite Tech Stocks Week Ahead: Rocket Lab’s $816M Space Force Win, AST SpaceMobile’s BlueBird 6 Launch, and EchoStar’s Spectrum Spotlight

The U.S. Space Development Agency awarded about $3.5 billion to Lockheed Martin, L3Harris, Northrop Grumman, and Rocket Lab for 72 missile-tracking satellites, with launches set for fiscal 2029. Rocket Lab called the $805 million deal its largest contract yet. U.S. stock markets will close early Dec. 24 and remain shut Dec. 25, thinning liquidity and amplifying moves in space sector stocks.
21 December 2025
······
Military Tech Stocks Week Ahead (Dec. 22–26, 2025): Space Force Satellite Awards, Drone Dominance, and Analyst Calls in Focus

Military Tech Stocks Week Ahead (Dec. 22–26, 2025): Space Force Satellite Awards, Drone Dominance, and Analyst Calls in Focus

The U.S. Space Force’s Space Development Agency awarded $3.5 billion in contracts to Lockheed Martin, L3Harris, Northrop Grumman, and Rocket Lab to build 72 Tracking Layer satellites for missile defense. Each company will deliver 18 satellites under fixed-price agreements. The contracts mark a shift toward recurring tech upgrades in defense spending. Markets may see outsized moves due to thin holiday trading.
21 December 2025
······
Data Center Stocks Week Ahead: AI Capex Scrutiny, Power Constraints, and Holiday Trading Put Nvidia, Vertiv, and Data Center REITs in Focus

Data Center Stocks Week Ahead: AI Capex Scrutiny, Power Constraints, and Holiday Trading Put Nvidia, Vertiv, and Data Center REITs in Focus

Global data center dealmaking hit a record $61 billion in 2025 through November, surpassing last year’s high, S&P Global data showed. The surge comes as investors question the sustainability of debt-heavy AI expansion and rising electricity costs. Parts of the AI sector rebounded late in the week. U.S. markets face thin holiday trading with early closure Dec. 24 and a full close Dec. 25.
21 December 2025
·
Software and Platform Stocks Week Ahead: AI Spending Scrutiny, Cloud Security Mega-Deals, and Holiday-Shortened Trading (Dec. 22–26, 2025)

Software and Platform Stocks Week Ahead: AI Spending Scrutiny, Cloud Security Mega-Deals, and Holiday-Shortened Trading (Dec. 22–26, 2025)

Google Cloud and Palo Alto Networks announced an expanded partnership with a contract approaching $10 billion, according to Reuters sources. Software and platform stocks faced volatile trading ahead of Christmas week, as investors weighed thin markets and questions about AI infrastructure payback. Wall Street also tracked shifting expectations for Federal Reserve rate cuts in 2026.
21 December 2025
········
Bank Stocks Week Ahead: Fed “Pause” Signals, Holiday-Thin Trading, and Buybacks Put Financials in Focus (Dec. 22–26, 2025)

Bank Stocks Week Ahead: Fed “Pause” Signals, Holiday-Thin Trading, and Buybacks Put Financials in Focus (Dec. 22–26, 2025)

Federal Reserve officials signaled no urgency for further rate cuts, with New York Fed President John Williams and Cleveland Fed President Beth Hammack both emphasizing a steady approach. Key U.S. economic data delayed by a government shutdown will be released during a shortened Christmas trading week, increasing uncertainty for bank stocks. Markets will close Dec. 25; volatility may rise due to thin liquidity.
21 December 2025
··············
Renewable Energy Stocks Week Ahead: Offshore Wind Wins, Grid Spending, and Data‑Center Power Demand in Focus (Dec 22–26, 2025)

Renewable Energy Stocks Week Ahead: Offshore Wind Wins, Grid Spending, and Data‑Center Power Demand in Focus (Dec 22–26, 2025)

Poland’s first competitive offshore wind auction on Dec. 17 awarded 3.4 GW of capacity across three Baltic Sea projects, with 25-year Contracts for Difference at €113–€117/MWh. Renewable energy stocks face thin holiday liquidity and heightened rate sensitivity as U.S. and European exchanges shorten trading hours for Christmas week. Investors are watching for shifts in 2026 rate cut expectations and sector growth outlooks.
21 December 2025
·
1 … 55 56 57 58 59 … 385

Stock Market Today

  • US Orange Inc Taps Advisors for Nasdaq IPO Preparation
    June 3, 2026, 8:03 PM EDT. US Orange Inc, an AR (augmented reality) glasses maker, has engaged financial advisors to prepare for a potential initial public offering (IPO) on the Nasdaq stock exchange, signaling plans to raise capital. Co-founded by Silicon Valley inventor Darwin Hu and MAS Capital, US Orange aims to leverage growing interest in AR technology. The IPO aims to provide funding for product development and market expansion in the competitive AR sector. Nasdaq is a major U.S. stock exchange known for tech listings. The move underscores increased investor enthusiasm in AR startups seeking to go public.

Latest articles

PVH Shares Drop After Results, But Quarter Wasn’t the Issue

PVH Shares Drop After Results, But Quarter Wasn’t the Issue

4 June 2026
PVH shares plunged 18.7% to $79.00 after hours as the Calvin Klein and Tommy Hilfiger owner slashed its full-year revenue outlook to roughly flat, citing ongoing pressure in Europe, the Middle East and Africa, overshadowing a first-quarter profit beat and signaling weaker second-quarter sales.
Nu Holdings Shares Fall After Analyst Downgrades and CFO Change

Nu Holdings Shares Fall After Analyst Downgrades and CFO Change

4 June 2026
Nu Holdings sank 2.43% to $11.64 after a second analyst downgrade in two days, as Susquehanna and BofA cited falling margins, rising credit risk, and uncertainty from an upcoming CFO change; credit loss allowances jumped 33% last quarter, while risk-adjusted net interest margin fell to 9.5%, raising concerns about Nu’s growth premium amid broader weakness in Brazilian bank stocks.
Intel shares snap losing streak as Wall Street eyes CPU rebound

Intel shares snap losing streak as Wall Street eyes CPU rebound

4 June 2026
Intel soared 4.43% to $112.71, snapping a five-day losing streak, after unveiling new Xeon 6+ CPUs and rack-scale AI infrastructure at Computex, positioning CPUs as central to AI buildouts and sparking renewed investor interest despite ongoing risks from rivals and rising chip costs.
Five Below Drops After Strong Quarter as Traders React

Five Below Drops After Strong Quarter as Traders React

4 June 2026
Five Below stock plunged 12.6% after hours to $194.87 despite first-quarter sales and profit beating estimates and raised full-year guidance, as investors focused on management’s warnings about rising fuel costs, sticky inflation, and a tougher consumer backdrop that could threaten the chain’s strong sales momentum.
Netskope Shares Fall After Earnings Beat

Netskope Shares Fall After Earnings Beat

4 June 2026
Netskope shares plunged nearly 20% after hours to $9.96 as investors focused on negative free cash flow of $57.2 million and slowing net new ARR, despite 28% revenue growth and a raised 2027 forecast, leaving the stock well below its $19 IPO price and highlighting concerns over sales execution and cash generation.
Go toTop